CDK1 has been reported to be overexpressed in a variety of malignancies, including pancreatic adenocarcinoma, hepatoma, colorectal carcinoma, and head and neck cancers [53,54], indicating that it plays a significant role in cell-cycle regulation and cancer formation. Here, CDK1 is linked to hepatocellular carcinoma.